![](/img/cover-not-exists.png)
1008PDZUMA-4 preliminary results: phase 1 study of KTE-C19 chimeric antigen receptor T cell therapy in pediatric and adolescent patients (pts) with relapsed/refractory acute lymphoblastic leukemia (R/R ALL)
Lee, D.W., Wayne, A.S., Huynh, V., Handgretinger, R., Pieters, R., Michele, G., Baruchel, A., Feuchtinger, T., Bertrand, Y., Hemiston, M., Brown, P.A., Rossi, J., Jiang, Y., Navale, L., Stout, S., AycVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx373.014
Date:
September, 2017
File:
PDF, 67 KB
english, 2017